5:07 PM
 | 
Aug 26, 2013
 |  BC Extra  |  Company News

Chiesi to acquire rare disease company Zymenex

Chiesi Farmaceutici S.p.A. (Parma, Italy) will acquire rare disease company Zymenex A/S (Hillerod, Denmark) for an...

Read the full 70 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >